Screener
Arcutis Biotherapeutics, Inc. ARQT Prepaid clinical trial costs
Prepaid clinical trial costs at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept arqt:PrepaidClinicalTrialTestCostsCurrent.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
FAQ
- What is Arcutis Biotherapeutics, Inc.'s prepaid clinical trial costs?
- Arcutis Biotherapeutics, Inc. (ARQT) reported prepaid clinical trial costs of $2.79M in Q2 2026.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s prepaid clinical trial costs?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s prepaid clinical trial costs has grown at a -11.9% compound annual growth rate (CAGR), from $4.87M to $2.58M.
- What does prepaid clinical trial costs mean?
- Prepaid clinical trial costs as reported by Arcutis Biotherapeutics, Inc. Common Stock.
Ask your AI about Arcutis Biotherapeutics, Inc.'s prepaid clinical trial costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude